Importance of biopsy of new bone lesions in patients with previous carcinoma

Clinical Orthopaedics and Related Research

Volumn 451, Issue , 2006, Pages 208-211

  Clayer, Mark ^a   Duncan, William ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BONE BIOPSY; BONE LESION; BONE METASTASIS; BREAST CARCINOMA; CALCANEUS; CANCER LOCALIZATION; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; HUMERUS; KIDNEY CARCINOMA; LATENT PERIOD; LUNG CARCINOMA; MALE; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; RIB; THERAPEUTIC ERROR; TIBIA; TISSUE NECROSIS; BIOPSY; BONE TUMOR; BONES OF THE ARM AND HAND; BONES OF THE LEG AND FOOT; BREAST TUMOR; CARCINOMA; COLORECTAL TUMOR; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; SPINE; TIME; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE NEOPLASMS; BONES OF LOWER EXTREMITY; BONES OF UPPER EXTREMITY; BREAST NEOPLASMS; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RIBS; SPINE; TIME FACTORS; UROGENITAL NEOPLASMS;

EID: 33749443455     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000229296.52216.77     Document Type: Article

References (14)

1. Aaron AD. Current concepts review: treatment of metastatic adenocarcinoma of the pelvis and the extremities. J Bone Joint Surg Am. 1997;79:917-932.
2. Baloch KG, Grimer RJ, Carter SR, Tillman RM. Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br. 2000;82:62-67.
3. Berenson JR, Rosen LS, Howell A. Porter L, Coleman RE, Morley W, Dreicer R, Kuross SA, Lipton A, Seaman JJ. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer. 2001;91:1191-1200.
4. Berenson JR, Vescio R, Henick K. Nishikubo C, Rettig M, Swift RA, Conde F, Von Teichert JM. A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease. Cancer. 2001;91:144-154.
5. Bukowski RM. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer. 1997;80:1198-1220.
6. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(8 suppl):1588-1594.
7. Damron TA, Sim FH. Surgical treatment for metastatic disease of the pelvis and the proximal end of the femur. Instr Course Lect. 2000;49:461-470.
8. Galasko CS. Diagnosis of skeletal metastases and assessment of response to treatment. Clin Orthop Relat Res. 1995;312:64-75.
9. Harrington KD. Orthopedic surgical management of skeletal complications of malignancy. Cancer. 1997;80:1614-1627.
10. Hefele MS. Surgical treatment of pathologic peritrochanteric femur fractures caused by metastatic disease. Curr Opin Orthop. 1998;9:62-68.
11. McNeil BJ. Value of bone scanning in neoplastic disease. Semin Nucl Med. 1984;14:277-286.
12. Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989;249:256-264.
13. Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasms with incidence and localization of skeletal metastasis: an analysis of 1,355 diphosphonate bone scans. J Nucl Med. 1975;16:986-989.
14. Townsend PW, Rosenthal HG, Smalley SR. Cozad SC, Hassanein RE. Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol. 1994;12:2345-2350.